Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, 1090, Belgium
NCT Number: NCT00953628
The purpose of this study is to investigate any potential advantages of replacing human chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for final oocyte maturation with regard to Ovarian hyperstimulation syndrome (OHSS)pathophysiology, endometrium receptivity and embryo quality and clinical pregnancy.
Looking for future studies?
Notify Me20 year–36 year
Female
Interventional
Phase 4
Brussels, Jette, 1090, Belgium
Biopsies of endometrium were taken in different groups Pregnancy rates were compared among defferent groups
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
bolus 10000 units for ovulation triggering
Other names: Pregnyl
bolus 250 mcg for ovulation triggering in IVF patients
Other names: Ovitrelle
Time frame: day of oocytre pick up
Time frame: 14 days after oocyte pick up
Universitair Ziekenhuis Brussel
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details